ICD variantPostprocedural heart failure following other surgery is a specific ICD-10 coded subtype of Heart Failure. The clinical content below covers Heart Failure in general.
CardiologysevereICD-10 · I97.131
Postprocedural heart failure following other surgery.Care & specialists in India
In India, postprocedural heart failure following other surgery is managed by cardiologists. Heart failure is a clinical syndrome in which the heart cannot pump enough blood at the pressures the body needs, producing breathlessness, fatigue, and fluid retention. About 6.7 million US adults are affected and the lifetime risk after age 40 is roughly 1 in 4, driven mostly by hypertension and coronary artery disease.
aliases · Heart Failure (congestive heart failure, CHF)· Dil Ki Kamzori· Hridayavakaranam Kuraiv· reviewed May 12, 2026
Reviewed by AIHealz Medical Editorial Board · CardiologyLast reviewed May 12, 2026
About our board →§ 01
What it is
Heart failure (ICD-10: I50; I50.2 systolic, I50.3 diastolic, I50.4 combined, I50.9 unspecified) is a clinical syndrome defined by symptoms (dyspnea, fatigue, fluid retention) and signs (elevated jugular venous pressure, pulmonary crackles, peripheral edema) that result from a structural or functional cardiac abnormality which raises intracardiac pressures or reduces cardiac output at rest or during stress. The universal definition adopted by ACC/AHA/HFSA and ESC in 2021 also requires objective evidence of cardiac dysfunction — abnormal echocardiogram, elevated natriuretic peptides, or hemodynamic measurements. Heart failure is staged A through D: stage A is high-risk without structural disease; stage B is structural disease without symptoms; stage C is symptomatic disease; stage D is advanced disease requiring specialized interventions. The NYHA functional class (I-IV) describes symptom severity at the time of assessment.
key facts
- Prevalence
- ~6.7 million US adults; ~64 million people worldwide (AHA 2024 stats)
- Demographics
- Higher rates in Black adults and men; risk doubles each decade after age 50
- Avg. age
- Median age at first diagnosis 73; HFpEF skews older and more female
- Global cases
- ~64 million people; >1 million US hospitalizations per year for decompensation
- Specialist
- Cardiology
- ICD-10
- I97.131
§ 02
How you might notice it
The key symptoms of Postprocedural heart failure following other surgery are: Shortness of breath with activity that worsens steadily over days to weeks; later, breathlessness occurs at rest and limits speech in long sentences., Orthopnea — breathlessness when lying flat, relieved by sitting up or sleeping on 2-3 pillows. A specific symptom that signals elevated left-sided filling pressures., Paroxysmal nocturnal dyspnea — waking 1-3 hours after falling asleep gasping for air, relieved by sitting upright and walking to a window., Bilateral lower-extremity swelling that develops over days, pits with finger pressure, and worsens by evening. Severe cases extend to the thighs, sacrum, or abdomen., Weight gain of 1-2 kg over 3-5 days from fluid retention; a single most useful self-monitoring metric in chronic heart failure., Fatigue and exercise intolerance disproportionate to age — the patient can no longer carry groceries or climb a single flight of stairs without resting., Persistent dry or wet cough, often worse at night, sometimes producing pink frothy sputum during acute pulmonary edema..
§ 03
How it’s diagnosed
diagnosis
Heart failure diagnosis is clinical, anchored by symptoms (Framingham major and minor criteria are still useful) and confirmed by objective testing. The workup begins with a focused history (effort tolerance, orthopnea, paroxysmal nocturnal dyspnea, recent weight change) and an examination for elevated jugular venous pressure, S3 gallop, displaced apical impulse, bibasilar crackles, hepatomegaly, and pitting edema. The single most useful blood test is BNP or NT-proBNP — a level below the rule-out threshold (NT-proBNP <125 pg/mL in chronic ambulatory, <300 pg/mL in acute presentation) makes heart failure unlikely; levels above the rule-in threshold support the diagnosis but are not specific. Twelve-lead ECG looks for prior MI, left ventricular hypertrophy, conduction disease, and arrhythmia; a completely normal ECG makes systolic HF less likely. The diagnostic linchpin is transthoracic echocardiogram, which yields left ventricular ejection fraction, chamber sizes, wall thickness, valvular function, and diastolic indices — and so determines whether the patient has HFrEF, HFmrEF, or HFpEF. Additional testing — coronary angiography or CT coronary angiography for suspected ischemic cause, cardiac MRI for suspected infiltrative disease, viability imaging before revascularization, right heart catheterization in selected cases — is targeted to the phenotype. Once heart failure is established, a search for the underlying cause is mandatory; reversible causes (tachycardia-mediated cardiomyopathy, alcoholic cardiomyopathy, peripartum cardiomyopathy, severe valve disease) change treatment trajectory.
Key tests
01
§ 04
Treatment & cost
medical treatments
- ✓Sacubitril-valsartan (24/26 mg twice daily; titrate to 97/103 mg twice daily)
- ✓Carvedilol, metoprolol succinate, or bisoprolol
- ✓Spironolactone (12.5-25 mg daily; up to 50 mg) or eplerenone (25-50 mg daily)
- ✓Dapagliflozin or empagliflozin (10 mg daily)
surgical options
Coronary revascularization (CABG or PCI)CABG reduces all-cause mortality by ~16% over 10 years versus medical therapy alone in STICH-eligible patients with ischemic HFrEF.
Valve repair or replacement (surgical or transcatheter)TAVR for severe AS in HF reduces mortality by 30-40% at 1 year vs medical therapy; COAPT showed 47% reduction in HF hospitalization with MitraClip in selected secondary MR.
Cardiac resynchronization therapy (CRT)~30% relative reduction in HF hospitalization and mortality in CARE-HF; ~70% are clinical responders.
Implantable cardioverter-defibrillator (ICD)23% relative reduction in mortality (SCD-HeFT) over 5 years in HFrEF on background medical therapy.
§ 05
Causes & risk factors
known causes
- Coronary artery disease and prior myocardial infarction
- Ischemic cardiomyopathy is the leading cause of HFrEF in high-income countries. Myocardial infarction destroys functioning muscle and triggers maladaptive remodeling. About two-thirds of HFrEF cases worldwide have an ischemic etiology.
- Long-standing hypertension
- Chronically elevated afterload produces left ventricular hypertrophy, diastolic stiffness, and ultimately systolic decline. Hypertension is the leading single risk factor for HFpEF and the second-leading for HFrEF after coronary disease.
- Valvular heart disease
- Severe aortic stenosis, aortic regurgitation, mitral regurgitation, and mitral stenosis all impose pressure or volume overload that culminates in heart failure. Valve surgery or transcatheter intervention can reverse the syndrome early in the course.
- Cardiomyopathies (dilated, hypertrophic, restrictive)
- Genetic and acquired myocardial diseases produce systolic or diastolic dysfunction independent of coronary disease. Dilated cardiomyopathy is the most common HF cause in patients under 60; titin and lamin gene variants are increasingly identified.
- Atrial fibrillation with rapid ventricular response
- Sustained tachycardia (>110 bpm for weeks) causes tachycardia-induced cardiomyopathy in some patients. Rate or rhythm control can fully reverse HF in this subgroup.
- Diabetes, obesity, and metabolic syndrome
- Obesity and type 2 diabetes drive both HFrEF and especially HFpEF through microvascular disease, myocardial lipid accumulation, systemic inflammation, and AGE-mediated stiffening. They roughly double HF lifetime risk.
- Cardiotoxic drugs and substances
- Anthracycline chemotherapy (doxorubicin), trastuzumab, certain tyrosine kinase inhibitors, immune checkpoint inhibitors, methamphetamine, cocaine, and heavy chronic alcohol use cause cardiomyopathy. Risk is dose-related and often partially reversible if recognized early.
§ 06
Living with it
recommended foods
- •DASH-style eating: vegetables, fruit, whole grains, lean protein, low-fat dairy, nuts and seeds
- •Mediterranean dietary pattern — associated with ~30% lower HF incidence in PREDIMED
§ 07
When to seek help
why see a cardiology
Refer to a cardiologist or heart-failure specialist at first diagnosis, after any hospitalization for decompensation, when starting or up-titrating quadruple therapy, when LVEF is below 35%, when ICD or CRT eligibility is being considered, when the cause is unclear, or for advanced therapies (LVAD, transplant). Stage D heart failure specifically warrants referral to a dedicated advanced HF program.
Find specialists →Related conditions
Coronary Artery DiseaseThe leading cause of HFrEF in high-income countries.Read →High Blood PressureThe leading single risk factor for HFpEF and a major contributor to HFrEF.Read →Atrial FibrillationCoexists with HF in 30-40% of patients; each worsens the other and requires integrated management.Read →Ischemic CardiomyopathyThe ischemic subtype of HFrEF, defined by underlying coronary artery disease.Read →Dilated CardiomyopathyThe most common non-ischemic cause of HFrEF in adults under 60; often genetic.Read →
Easily confused with
vs. Postprocedural heart failure following other surgery
Coronary Artery DiseaseCoronary artery disease is the most common cause of HFrEF, but the two are distinct. CAD presents with angina or MI and is diagnosed by coronary imaging; HF is diagnosed by symptoms plus structural cardiac dysfunction on echo. A patient can have one without the other.Compare →vs. Postprocedural heart failure following other surgery
Atrial FibrillationAF causes palpitations and irregular pulse without necessarily impairing pump function. HF causes symptoms even in sinus rhythm. The two frequently coexist; rapid AF can trigger HF, and HF predisposes to AF.Compare →vs. Postprocedural heart failure following other surgery
High Blood PressureHypertension is a single risk factor; HF is a multi-organ clinical syndrome that hypertension causes over years. A patient can have severe hypertension with normal heart function or established HF after years of poorly controlled BP.Compare →vs. Postprocedural heart failure following other surgery
COPDBoth cause exertional breathlessness, but COPD primarily produces wheeze, prolonged expiration, and barrel chest; HF produces orthopnea, pedal edema, and an S3 gallop. The two coexist commonly; spirometry plus BNP and echo separate them.Compare →Often appears alongside
Types and stages
Living with Postprocedural heart failure following other surgery
Timeline
After an acute decompensation, congestion typically resolves over 3-7 days of inpatient diuresis and oral therapy is initiated or up-titrated during the same admission. Most patients reach a new functional baseline within 4-6 weeks. With rapid quadruple-therapy titration over 6 weeks per STRONG-HF, EF improvement (in HFrEF) is often visible at 3-6 months; full myocardial reverse remodeling can continue for 12 months or more. Cardiac rehabilitation across 8-12 weeks measurably improves exercise tolerance and quality of life.
Lifestyle
- 01Weigh daily on the same scale at the same time and report a 1.4 kg gain over 2 days or 2.3 kg gain over a week.
- 02Restrict sodium to under 2 g per day during decompensation; under 3 g per day in stable chronic HF.
- 03Limit fluid intake to 1.5-2.0 L per day if hyponatremia or severe congestion is present; loose restriction in mild HF.
- 04Perform structured aerobic exercise 30-45 minutes most days, ideally through a cardiac rehabilitation program.
- 05Take an annual influenza vaccine and the recommended pneumococcal and COVID-19 vaccines.
- 06Avoid NSAIDs — they retain sodium and water, raise blood pressure, and trigger decompensation.
- 07Sleep with the head of the bed elevated 20-30° if orthopnea is present, and seek evaluation for sleep apnea.
- 08
Complementary approaches
Cardiac rehabilitationSupervised exercise training plus risk-factor education for 8-12 weeks. Improves peak VO2, quality of life, and reduces HF readmission by ~25% (HF-ACTION subgroup analyses).
Choosing a doctor
For complex heart failure, choose a cardiologist who is board certified in cardiovascular disease and ideally fellowship trained in advanced heart failure and transplant cardiology. Look for affiliation with a heart-failure clinic offering rapid in-hospital titration (STRONG-HF protocol), device programs (ICD/CRT), and where applicable, LVAD and transplant capability. For HFpEF, expertise in evaluating diastolic function, exclusion of cardiac amyloidosis, and management of co-morbid hypertension, AF, and obesity is essential.
Patient support resources
American Heart Association — Heart Failure →Patient-facing overview, self-management tools, and links to support groups.
Heart Failure Society of America (HFSA) →Patient education from the specialty society; resources by stage and topic.
Mended Hearts →Peer-to-peer support network for adults with heart disease and their families.
British Heart Foundation — Heart Failure →Plain-English explanations of diagnosis, treatments, and recovery for UK readers.
§ 08
Frequently asked
§ 09
Sources & references
- 01
- 02
- 03
- 04
- 05
verified specialists
View all specialists →Top Cardiologists in India.
Ranked by patient outcomes and specialized experience.
take control
Connect with top Cardiologists in India.
Specialists who treat Postprocedural heart failure following other surgery. Get expert guidance and personalized care.